You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

JAK1 inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Hepatocellular Carcinoma Trial in London (Itacitinib (INCB039110))

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Itacitinib (INCB039110)
  • London, United Kingdom
    Imperial College Healthcare NHS Trust
Jul 14, 2022

Severe Aplastic Anemia, Single Lineage Cytopenias, T-LGL, Hypoplastic MDS Trial run by the National Heart, Lung, and Blood

Not yet recruiting
  • Severe Aplastic Anemia
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 23, 2023

Rheumatoid Arthritis, JAK Inhibitor, IL-6 Inhibitor Trial in Nagasaki (filgotinib 200mg/day, subcutaneous tocilizumab

Recruiting
  • Rheumatoid Arthritis
  • +4 more
  • filgotinib 200mg/day
  • subcutaneous tocilizumab 162mg/biweekly
  • Nagasaki, Japan
    Nagasaki University Hospital
Oct 23, 2021

Bronchiolitis Obliterans Trial in Houston (Itacitinib, Itacitinib Adipate)

Recruiting
  • Bronchiolitis Obliterans
  • Houston, Texas
    M D Anderson Cancer Center
Jan 24, 2023

Cicatricial Alopecia Trial in New York (PF-06700841, Placebo)

Recruiting
  • Cicatricial Alopecia
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Aug 16, 2022

Chronic GVHD, Chronic GVHD Trial run by the NCI (Baricitinib)

Active, not recruiting
  • Chronic Graft vs Host Disease
  • Chronic Graft-Versus-Host Disease
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 29, 2022

Chronic Hand Dermatitis Trial in Rochester (Ruxolitinib)

Recruiting
  • Chronic Hand Dermatitis
  • Rochester, New York
    UR Medicine Dermatology College Town
Aug 9, 2022

Idiopathic Inflammatory Myopathies Trial in London (Baricitinib)

Recruiting
  • Idiopathic Inflammatory Myopathies
  • London, United Kingdom
    King's College Hospital NHS Foundation Trust
May 19, 2022

Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma Trial in Seattle

Recruiting
  • Metastatic Leiomyosarcoma
  • +17 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 13, 2022

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, other, radiation)

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 10, 2023

Vitiligo, Effect of Drug Trial (JAK-2 inhibitor, Topical corticosteroid)

Not yet recruiting
  • Vitiligo
  • Effect of Drug
  • JAK-2 inhibitor
  • Topical corticosteroid
  • (no location specified)
Mar 19, 2022

Myelofibrosis Trial in Canton (Jaktinib Hydrochloride Tablet)

Recruiting
  • Myelofibrosis
  • Jaktinib Hydrochloride Tablet
  • Canton, Ohio
    Site 01
Aug 18, 2022

Active Non-anterior Non-infectious Uveitis Trial (Baricitinib 4 MG)

Not yet recruiting
  • Active Non-anterior Non-infectious Uveitis
  • Baricitinib 4 MG
  • (no location specified)
Dec 7, 2022

Rheumatoid Arthritis Trial (Baricitinib 4 MG, Placebo)

Not yet recruiting
  • Rheumatoid Arthritis
  • Baricitinib 4 MG
  • Placebo
  • (no location specified)
Jul 27, 2023

Sarcoidosis Trial in New Haven (Abrocitinib 200 mg)

Not yet recruiting
  • Sarcoidosis
  • Abrocitinib 200 mg
  • New Haven, Connecticut
    Yale University
Jan 24, 2023

Myelofibrosis, Moderate Thrombocytopenia Trial (Selinexor)

Not yet recruiting
  • Myelofibrosis
  • Moderate Thrombocytopenia
  • (no location specified)
Jul 31, 2023

Acneiform Eruptions Trial in Shanghai (Cream containing JAK Inhibitor)

Recruiting
  • Acneiform Eruptions
  • Cream containing JAK Inhibitor
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Jun 20, 2022

JAK Inhibition in Ulcerative Colitis

Not yet recruiting
  • Analyzing Immune Composition Changes Upon JAK Inhibitor Treatment of Ulcerative Colitis Patients
  • JAK inhibitor treatment
  • (no location specified)
Jul 11, 2022

Abatacept, Treatment Compliance, Rheumatoid Arthritis Trial in Hangzhou (Janus Kinase Inhibitor, Abatacept)

Recruiting
  • Abatacept
  • +2 more
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial People's Hospital
Jul 5, 2022

Vitiligo, JAK Inhibitor Trial in Canada, United States (Ruxolitinib 1.5% cream, NB-UVB phototherapy)

Recruiting
  • Vitiligo
  • JAK Inhibitor
  • Ruxolitinib 1.5% cream
  • NB-UVB phototherapy
  • Fountain Valley, California
  • +13 more
Jul 6, 2022

Hemophagocytic Lymphohistiocytoses, Cytokine Storm Trial in Hangzhou (Dexamethasone, Etoposide, Ruxolitinib)

Not yet recruiting
  • Hemophagocytic Lymphohistiocytoses
  • Cytokine Storm
  • Hangzhou, Zhejiang, China
    The Children's Hospital of Zhejiang University School of Medicin
Aug 4, 2022

Rheumatoid Arthritis Patients Treated With JAK-inhibitor

Recruiting
  • Rheumatoid Arthritis
  • Upadacitinib <15 MG [Rinvoq]
  • Montpellier, France
    CHU de Montpellier
Jan 12, 2022

Alopecia Areata Trial in Sohag (Janus Kinase 1 and 2)

Recruiting
  • Alopecia Areata
  • Janus Kinase 1 and 2
  • Sohag, Egypt
    Sohag University hospitals
May 12, 2023

Cicatricial Alopecia Trial in New York (PF-06651600)

Not yet recruiting
  • Cicatricial Alopecia
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Sep 19, 2022

Graft-versus-host-disease, Graft Vs Host Disease Trial in Saint Louis (Baricitinib)

Recruiting
  • Graft-versus-host-disease
  • Graft Vs Host Disease
  • Saint Louis, Missouri
    Washington University School of Medicine
Mar 4, 2022